Prion kinetics and toxicity and their wider relevance in neurodegenerative disease
In plain English
AI plain-English summaryPrion diseases and common dementias like Alzheimer’s share a core mechanism: normal brain proteins clump into fibres called amyloid, which multiply, spread, and damage brain cells. Researchers at the MRC Prion Unit have already shown that prions themselves are not directly toxic—another form of the prion protein is the real culprit. This project will isolate and characterise that toxic species to understand how it kills neurons. The team will also develop faster methods to measure prions and their toxicity. Crucially, they discovered that amyloid seeds from Alzheimer’s can, in rare medical accidents, act like prions and transmit disease in humans. They now find that these seeds exist in different strains, much like classical prions, which may explain why Alzheimer’s progresses differently in different people. This is fundamental science. If successful, it could reveal why some protein aggregates are harmless while others destroy brain tissue, and identify strain-specific targets for therapies. That knowledge might eventually help design drugs that block the toxic species—not just for rare prion diseases, but for the millions affected by Alzheimer’s and other dementias.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
IntramuralPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know